Brown Advisory
MBII

Brown Advisory’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Brown Advisory’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-12,048
Closed -$9K – 1313
2021
Q4 		$9K Hold
12,048
– – ﹤0.01% 1236
2021
Q3 		$11K Buy
+12,048
New +$14.5K ﹤0.01% 1103

Other funds holding MBII

AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory's MBII Position: Q1 2022 in Review

Brown Advisory sold out of Marrone Bio Innovations, Inc. (MBII) in Q1 2022, closing a stake of 12,048 shares — an estimated $9K sold.

Brown Advisory first reported a position in MBII in Q3 2021 and held it in 2 quarters. The position peaked at $11K in Q3 2021. 71 funds tracked by Wall St. Rank hold MBII as of Q1 2022.

  • Brown Advisory reported no remaining Marrone Bio Innovations, Inc. position as of Q1 2022 after selling out during the quarter.
  • Brown Advisory sold 12,048 Marrone Bio Innovations, Inc. shares in Q1 2022, an estimated $9K.
  • Brown Advisory first reported a position in Marrone Bio Innovations, Inc. in Q3 2021 and held it in 2 quarters.
  • Brown Advisory's Marrone Bio Innovations, Inc. position peaked at $11K in Q3 2021.
  • 71 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q1 2022.

Based on Brown Advisory's 13F filing for Q1 2022, filed 9 May 2022.